Abd El-Hack ME, El-Saadony MT, Swelum AA et al (2021) Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability. J Sci Food Agric 101:5747–5762. https://doi.org/10.1002/jsfa.11372
Article CAS PubMed Google Scholar
Adani G, Filippini T, Michalke B, Vinceti M (2020) Selenium and Other Trace Elements in the Etiology of Parkinson’s Disease: A Systematic Review and Meta-Analysis of Case-Control Studies. Neuroepidemiology 54:1–23. https://doi.org/10.1159/000502357
Alcalay RN, Gu Y, Mejia-Santana H et al (2012) The association between Mediterranean diet adherence and Parkinson’s disease. Move Dis 27:771–774. https://doi.org/10.1002/mds.24918
Al-kuraishy HM, Al-Gareeb AI, Alexiou A et al (2023) Pros and cons for statins use and risk of Parkinson’s disease: An updated perspective. Pharmacol Res Perspect. https://doi.org/10.1002/prp2.1063
Article PubMed PubMed Central Google Scholar
Amara AW, Memon AA (2018) Effects of Exercise on Non-motor Symptoms in Parkinson’s Disease. Clin Ther 40:8–15. https://doi.org/10.1016/j.clinthera.2017.11.004
Anderson G, Noorian A, Taylor G et al (2007) Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson’s disease. Exp Neurol 207:4–12. https://doi.org/10.1016/j.expneurol.2007.05.010
Article CAS PubMed PubMed Central Google Scholar
Angelopoulou E, Bougea A, Hatzimanolis A et al (2024) Mild Behavioral Impairment in Parkinson’s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects. Medicina (B Aires) 60:115. https://doi.org/10.3390/medicina60010115
Ascherio A, LeWitt PA, Xu K et al (2009) Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol 66:1460–1468. https://doi.org/10.1001/archneurol.2009.247
Article PubMed PubMed Central Google Scholar
Aune D, Schlesinger S, Mahamat-Saleh Y et al (2023) Diabetes mellitus, prediabetes and the risk of Parkinson’s disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases. Eur J Epidemiol 38:591–604. https://doi.org/10.1007/s10654-023-00970-0
Article PubMed PubMed Central Google Scholar
Babulal GM, Quiroz YT, Albensi BC et al (2019) Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: Update and areas of immediate need. Alzheimer’s & Dementia 15:292–312. https://doi.org/10.1016/j.jalz.2018.09.009
Barichella M, Marczewska A, De Notaris R et al (2006) Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson’s disease. Move Dis 21:1682–1687. https://doi.org/10.1002/mds.21003
Barichella M, Savardi C, Mauri A et al (2007) Diet with LPP for renal patients increases daily energy expenditure and improves motor function in Parkinsonian patients with motor fluctuations. Nutr Neurosci 10:129–135. https://doi.org/10.1080/10284150701414046
Article CAS PubMed PubMed Central Google Scholar
Barichella M, Pacchetti C, Bolliri C et al (2016) Probiotics and prebiotic fiber for constipation associated with Parkinson disease. Neurology 87:1274–1280. https://doi.org/10.1212/WNL.0000000000003127
Article CAS PubMed Google Scholar
Barichella M, Cereda E, Pinelli G et al (2019) Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome. Neurology 93:E485–E496. https://doi.org/10.1212/WNL.0000000000007858
Article CAS PubMed Google Scholar
Bloem BR, Okun MS, Klein C (2021) Parkinson’s disease. The Lancet 397:2284–2303. https://doi.org/10.1016/S0140-6736(21)00218-X
Bluett B, Togasaki DM, Mihaila D et al (2021) Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression. JAMA 326:926. https://doi.org/10.1001/jama.2021.10207
Borzabadi S, Oryan S, Eidi A et al (2018) The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin and Lipid in Patients with Parkinson’s Disease: A Randomized, Double-blind, PlaceboControlled Trial. Arch Iran Med 21:289–295
Braak H, Ghebremedhin E, Rüb U et al (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134. https://doi.org/10.1007/s00441-004-0956-9
Braak H, de Vos RAI, Bohl J, Del Tredici K (2006) Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72. https://doi.org/10.1016/j.neulet.2005.11.012
Article CAS PubMed Google Scholar
Burgos R, Bretón I, Cereda E et al (2018) ESPEN guideline clinical nutrition in neurology. Clin Nutr 37:354–396. https://doi.org/10.1016/j.clnu.2017.09.003
Cacabelos R (2017) Parkinson’s Disease: From Pathogenesis to Pharmacogenomics. Int J Mol Sci 18:551. https://doi.org/10.3390/ijms18030551
Article CAS PubMed PubMed Central Google Scholar
Caioni G, Cimini A, Benedetti E (2022) Food Contamination: An Unexplored Possible Link between Dietary Habits and Parkinson’s Disease. Nutrients 14:1467. https://doi.org/10.3390/nu14071467
Article CAS PubMed PubMed Central Google Scholar
Choi A, Hallett M, Ehrlich D (2021) Nutritional Ketosis in Parkinson’s Disease — a Review of Remaining Questions and Insights. Neurotherapeutics 18:1637–1649. https://doi.org/10.1007/s13311-021-01067-w
Article PubMed PubMed Central Google Scholar
Choi AH, Delgado M, Chen KY et al (2024) A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson’s disease. BMC Neurol. https://doi.org/10.1186/s12883-024-03603-5
Article PubMed PubMed Central Google Scholar
Cilia R, Laguna J, Cassani E et al (2017) Mucuna pruriens in Parkinson disease. Neurology 89:432–438. https://doi.org/10.1212/WNL.0000000000004175
Article CAS PubMed PubMed Central Google Scholar
Cilia R, Laguna J, Cassani E et al (2018) Daily intake of Mucuna pruriens in advanced Parkinson’s disease: A 16-week, noninferiority, randomized, crossover, pilot study. Parkinsonism Relat Disord 49:60–66. https://doi.org/10.1016/j.parkreldis.2018.01.014
Coe S, Andreoli D, George M et al (2022) A feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue and fatigability in people with Parkinson’s (pwP). Clin Nutr ESPEN 48:68–73. https://doi.org/10.1016/j.clnesp.2022.01.023
Article CAS PubMed Google Scholar
Cucca A, Mazzucco S, Bursomanno A et al (2015) Amino acid supplementation in l-dopa treated Parkinson’s disease patients. Clin Nutr 34:1189–1194. https://doi.org/10.1016/j.clnu.2014.12.007
Article CAS PubMed Google Scholar
da Silva TM, Munhoz RP, Alvarez C et al (2008) Depression in Parkinson’s disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J Affect Disord 111:351–359. https://doi.org/10.1016/j.jad.2008.03.008
Article CAS PubMed Google Scholar
DiFrancisco-Donoghue J, Lamberg EM, Rabin E et al (2012) Effects of exercise and B vitamins on homocysteine and glutathione in Parkinson’s disease: A randomized trial. Neurodegener Dis 10:127–134. https://doi.org/10.1159/000333790
Comments (0)